| Immunologic and virologic status after 14 to 18 years of infection with an attenuated strain of HIV-1—a report from the Sydney Blood Bank Cohort JC Learmont, AF Geczy, J Mills, LJ Ashton, CH Raynes-Greenow, ... New England Journal of Medicine 340 (22), 1715-1722, 1999 | 457 | 1999 |
| Effects of CCR5-Δ 32, CCR2-64I, and SDF-1 3′A Alleles on HIV-1 Disease Progression: An International Meta-Analysis of Individual-Patient Data JPA Ioannidis, PS Rosenberg, JJ Goedert, LJ Ashton, TL Benfield, ... Annals of internal medicine 135 (9), 782-795, 2001 | 393 | 2001 |
| Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes B Ledergerber The Lancet 364 (9428), 51-62, 2004 | 391 | 2004 |
| miR-380-5p represses p53 to control cellular survival and is associated with poor outcome in MYCN-amplified neuroblastoma A Swarbrick, SL Woods, A Shaw, A Balakrishnan, Y Phua, A Nguyen, ... Nature medicine 16 (10), 1134-1140, 2010 | 237 | 2010 |
| Melaleuca alternifolia (tea tree) oil gel (6%) for the treatment of recurrent herpes labialis CF Carson, L Ashton, L Dry, DW Smith, TV Riley Journal of Antimicrobial Chemotherapy 48 (3), 450-451, 2001 | 208 | 2001 |
| Increased frequency of CCR-5 Δ32 heterozygotes among long-term non-progressors with HIV-1 infection GJ Stewart, LJ Ashton, RA Biti, RA Ffrench, BH Bennetts, NR Newcombe, ... Aids 11 (15), 1833-1838, 1997 | 155 | 1997 |
| Characterization of Three nef-Defective Human Immunodeficiency Virus Type 1 Strains Associated with Long-Term Nonprogression DI Rhodes, L Ashton, A Solomon, A Carr, D Cooper, J Kaldor, N Deacon Journal of virology 74 (22), 10581-10588, 2000 | 154 | 2000 |
| ABCC multidrug transporters in childhood neuroblastoma: clinical and biological effects independent of cytotoxic drug efflux MJ Henderson, M Haber, A Porro, MA Munoz, N Iraci, C Xue, J Murray, ... Journal of the National Cancer Institute 103 (16), 1236-1251, 2011 | 151 | 2011 |
| Chromosomal localization of the human alpha-L-iduronidase gene (IDUA) to 4p16. 3. HS Scott, LJ Ashton, HJ Eyre, E Baker, DA Brooks, DF Callen, ... American journal of human genetics 47 (5), 802, 1990 | 129 | 1990 |
| Persistence of HIV-1 transmitted drug resistance mutations H Castro, D Pillay, P Cane, D Asboe, V Cambiano, A Phillips, DT Dunn, ... The Journal of infectious diseases 208 (9), 1459-1463, 2013 | 124 | 2013 |
| Childhood acute lymphoblastic leukemia and indicators of early immune stimulation: a Childhood Leukemia International Consortium study J Rudant, T Lightfoot, KY Urayama, E Petridou, JD Dockerty, C Magnani, ... American journal of epidemiology 181 (8), 549-562, 2015 | 109 | 2015 |
| CCR5 promoter polymorphisms, CCR5 59029A and CCR5 59353C, are under represented in HIV-1-infected long-term non-progressors AO Clegg, LJ Ashton, RA Biti, P Badhwar, P Williamson, JM Kaldor, ... Aids 14 (2), 103-108, 2000 | 97 | 2000 |
| Buccal DNA collection: comparison of buccal swabs with FTA cards E Milne, FM van Bockxmeer, L Robertson, JM Brisbane, LJ Ashton, ... Cancer Epidemiology Biomarkers & Prevention 15 (4), 816-819, 2006 | 85 | 2006 |
| Immunoquantification and enzyme kinetics of alpha-L-iduronidase in cultured fibroblasts from normal controls and mucopolysaccharidosis type I patients. LJ Ashton, DA Brooks, PA McCourt, VJ Muller, PR Clements, JJ Hopwood American journal of human genetics 50 (4), 787, 1992 | 81 | 1992 |
| Maternal use of folic acid and other supplements and risk of childhood brain tumors E Milne, KR Greenop, C Bower, M Miller, FM Van Bockxmeer, RJ Scott, ... Cancer epidemiology, biomarkers & prevention 21 (11), 1933-1941, 2012 | 79 | 2012 |
| Buccal swabs and treated cards: methodological considerations for molecular epidemiologic studies examining pediatric populations SM Beckett, SJ Laughton, LD Pozza, GB McCowage, G Marshall, ... American journal of epidemiology 167 (10), 1260-1267, 2008 | 71 | 2008 |
| Clinical significance of minimal residual disease at day 15 and at the end of therapy in childhood acute lymphoblastic leukaemia R Sutton, NC Venn, J Tolisano, AY Bahar, JE Giles, LJ Ashton, L Teague, ... British journal of haematology 146 (3), 292-299, 2009 | 65 | 2009 |
| Analysis of N-acetylgalactosamine-4-sulfatase protein and kinetics in mucopolysaccharidosis type VI patients. DA Brooks, PA McCourt, GJ Gibson, LJ Ashton, M Shutter, JJ Hopwood American journal of human genetics 48 (4), 710, 1991 | 64 | 1991 |
| Breastfeeding and nutrition to 2 years of age and risk of childhood acute lymphoblastic leukemia and brain tumors KR Greenop, HD Bailey, M Miller, RJ Scott, J Attia, LJ Ashton, P Downie, ... Nutrition and cancer 67 (3), 431-441, 2015 | 49 | 2015 |
| Systemic non-Hodgkin lymphoma in individuals with known dates of HIV seroconversion: incidence and predictors Cascade Collaboration Aids 18 (4), 673-681, 2004 | 48 | 2004 |
